Remote monitoring enhances infection management in hematologic malignancies, reducing hospitalizations and improving patient communication for better outcomes.
James Essell, MD
Advertisement
James Essell, MD, is a medical oncologist at Sarah Cannon Research Institute at OHC, the US Oncology Network.
Articles by James Essell, MD
Discover how a remote therapeutic monitoring system enhances patient care and streamlines clinic operations, reducing hospitalizations for hematologic malignancies.
Remote therapeutic monitoring significantly lowers infection-related hospitalizations in hematological cancer patients, enhancing outpatient care and reducing emergency visits.
Advertisement
Latest Updated Articles
Dr Essell Discusses the Benefits of Remote Patient MonitoringPublished: December 9th 2025 | Updated:
Remote Monitoring Reduces Hospitalizations for Patients With Blood CancersPublished: December 12th 2025 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Accepts BLA for Ivonescimab in Pretreated EGFR-Mutated NSCLC
2
The Targeted Pulse: New Standards in Myeloma, Melanoma, and More
3
Onvansertib Triplet Shows Dose-Dependent Frontline Benefit in RAS-Mutant Metastatic CRC
4
Pembrolizumab/Lenvatinib Show Efficacy, Safety in Clear Cell Gyn Cancers
5